161
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Triglyceride–Glucose Index as a Novel Biomarker in the Occurrence of Kidney Stones: A Cross-Sectional Population-Based Study

, , , , , & ORCID Icon show all
Pages 6233-6244 | Published online: 29 Sep 2021

References

  • Pak CY. Kidney stones. Lancet. 1998;351(9118):1797–1801. doi:10.1016/S0140-6736(98)01295-1
  • Thongprayoon C, Krambeck AE, Rule AD. Determining the true burden of kidney stone disease. Nat Rev Nephrol. 2020;16(12):736–746. doi:10.1038/s41581-020-0320-7
  • Rule AD, Lieske JC, Pais VM. Management of kidney stones in 2020. JAMA. 2020;323(19):1961–1962. doi:10.1001/jama.2020.0662
  • Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet. 2001;358(9282):651–656. doi:10.1016/S0140-6736(01)05782-8
  • Scales CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–165. doi:10.1016/j.eururo.2012.03.052
  • Zisman AL. Effectiveness of treatment modalities on kidney stone recurrence. Clin J Am Soc Nephrol. 2017;12(10):1699–1708. doi:10.2215/CJN.11201016
  • Mao W, Zhang H, Xu Z, et al. Relationship between urine specific gravity and the prevalence rate of kidney stone. Transl Androl Urol. 2021;10(1):184–194. doi:10.21037/tau-20-929
  • Mao W, Wu J, Zhang Z, Xu Z, Xu B, Chen M. Neutrophil-lymphocyte ratio acts as a novel diagnostic biomarker for kidney stone prevalence and number of stones passed. Transl Androl Urol. 2021;10(1):77–86. doi:10.21037/tau-20-890
  • Carbone A, Al Salhi Y, Tasca A, et al. Obesity and kidney stone disease: a systematic review. Minerva urologica e nefrologica = Italian J Urol Nephrol. 2018;70(4):393–400.
  • Heise T, Zijlstra E, Nosek L, Heckermann S, Plum-Mörschel L, Forst T. Euglycaemic glucose clamp: what it can and cannot do, and how to do it. Diabetes Obes Metab. 2016;18(10):962–972. doi:10.1111/dom.12703
  • Hong S, Han K, Park CY. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimers Res Ther. 2021;13(1):9. doi:10.1186/s13195-020-00758-4
  • Spatola L, Ferraro PM, Gambaro G, Badalamenti S, Dauriz M. Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus. Metabolism. 2018;83:225–233. doi:10.1016/j.metabol.2018.02.008
  • Ando R, Suzuki S, Nagaya T, et al. Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol. 2011;18(2):131–138. doi:10.1111/j.1442-2042.2010.02690.x
  • Kim S, Chang Y, Jung HS, et al. Glycemic status, insulin resistance, and the risk of nephrolithiasis: a cohort study. Am J Kidney Dis. 2020;76(5):658–668.e1. doi:10.1053/j.ajkd.2020.03.013
  • Weinberg AE, Patel CJ, Chertow GM, Leppert JT. Diabetic severity and risk of kidney stone disease. Eur Urol. 2014;65(1):242–247. doi:10.1016/j.eururo.2013.03.026
  • Zhang D, Li S, Zhang Z, et al. Urinary stone composition analysis and clinical characterization of 1520 patients in central China. Sci Rep. 2021;11(1):6467. doi:10.1038/s41598-021-85723-3
  • Wang L, Cong HL, Zhang JX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. doi:10.1186/s12933-020-01054-z
  • Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8. doi:10.1186/s12933-019-0982-2
  • Dikaiakou E, Vlachopapadopoulou EA, Paschou SA, et al. Triglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents. Endocrine. 2020;70(1):58–64. doi:10.1007/s12020-020-02374-6
  • Wu TD, Fawzy A, Brigham E, et al. Association of triglyceride-glucose index and lung health: a population-based study. Chest. 2021;160(3):1026–1034. doi:10.1016/j.chest.2021.03.056
  • Wang S, Shi J, Peng Y, et al. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Cardiovasc Diabetol. 2021;20(1):82. doi:10.1186/s12933-021-01274-x
  • Su WY, Chen SC, Huang YT, et al. Comparison of the effects of fasting glucose, hemoglobin A(1c), and triglyceride-glucose index on cardiovascular events in type 2 diabetes mellitus. Nutrients. 2019;11(11):2838. doi:10.3390/nu11112838
  • Ma X, Dong L, Shao Q, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31. doi:10.1186/s12933-020-01006-7
  • Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Triglyceride-glucose index is a predictor of incident chronic kidney disease: a population-based longitudinal study. Clin Exp Nephrol. 2019;23(7):948–955. doi:10.1007/s10157-019-01729-2